Mode
Text Size
Log in / Sign up

Qualitative study of Swiss therapists explores psychotherapeutic factors in psychedelic-assisted therapy

Qualitative study of Swiss therapists explores psychotherapeutic factors in psychedelic-assisted the…
Photo by Navy Medicine / Unsplash
Key Takeaway
Consider qualitative findings on PAT's psychotherapeutic factors as preliminary insights from a small therapist sample.

This qualitative interview study explored how psychotherapeutic factors contribute to psychedelic-assisted therapy (PAT) within Switzerland's clinical framework, where such treatments can be implemented in long-term settings. Researchers interviewed 7 Swiss therapists about their experiences with PAT.

The thematic analysis of therapist interviews identified two main themes. First, psychotherapeutic techniques in PAT are adapted but retain similarities to non-psychedelic psychotherapy practices, supporting patients in having meaningful therapeutic experiences. Second, therapists described a synergistic relationship between psychedelics and psychotherapy that amplifies underlying general psychotherapeutic factors like trust, a sense of profundity, and the emergence of therapeutic experiences.

Therapists generally agreed that psychedelics work as unspecific catalysts for psychotherapeutic processes, while acknowledging potential psychopharmacological effects or unique interactions. Safety and tolerability data were not reported. The study has significant limitations: it is qualitative with a small sample (n=7), lacks quantitative efficacy or safety outcomes, and findings are specific to Switzerland's clinical framework. The authors suggest that for specific indications, incorporating psychedelics into long-term psychotherapeutic treatment may strengthen therapeutic processes, but this remains a hypothesis requiring rigorous testing.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
Research on the therapeutic effects of psychedelics in psychiatry, commonly referred to as Psychedelic-Assisted Therapy (PAT), has expanded substantially in recent years. The context-dependent nature of psychedelics has sparked discussion about the importance of the psychotherapeutic environment in achieving beneficial outcomes. This study explores the contribution of psychotherapeutic factors on PAT in Switzerland, where psychedelic treatments can be implemented within long-term clinical frameworks. Seven semi-structured interviews were conducted with Swiss therapists to explore how they frame psychedelic treatments and the role of the psychotherapeutic setting in facilitating therapeutic outcomes. Thereby, individual experiences of the patients as reported by the therapists, were particularly considered. Thematic analysis identified two main themes, each with several sub-themes. The first theme revealed that while psychotherapeutic techniques are adapted to PAT, they retain similarities to non-psychedelic psychotherapy practices, supporting patients in having meaningful therapeutic experiences. The second theme describes a synergistic relationship between psychedelics and psychotherapy, amplifying underlying general psychotherapeutic factors such as trust, a sense of profundity, and the emergence of therapeutic experiences. The interviewed therapists agreed that psychedelics work as unspecific catalysts for psychotherapeutic processes, while still acknowledging the potential for psychopharmacological effects or the interaction between psychedelics and psychotherapy to create unique psychotherapeutic processes. Findings from our sample suggest that, for specific indications, incorporating psychedelics into long-term psychotherapeutic treatment may strengthen therapeutic processes. Future research could investigate the efficacy of PAT within the framework of specific psychotherapeutic modalities or in different settings, including prospective quantitative assessments of outcomes. Ultimately, clarifying mechanisms of action of PAT may help to enhance its efficacy and potentially to integrate psychedelic treatments into mainstream mental health care.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.